FOUNTAIN HILLS, Ariz.,
March 9, 2011 /PRNewswire/ --
Sunridge International (OTC Bulletin Board: SNDZ), announced today
that it has appointed Charles B. Mathew CPA MBA as its CFO.
Sunridge CEO, G. Richard Smith
stated, "We are moving fast with our business plan. Recently
the company made the decision to move into company owned and
operated glaucoma treatment centers, to take advantage of the
tremendous amount of money to be made treating patients with our
patented PNT treatment for glaucoma and ocular hypertension.
While we are still expanding our distribution network around
the world, the added revenue brought in by our clinical operations
should accelerate the time needed to bring Sunridge to
profitability.
We are moving forward to complete funding for our first clinic.
Mr. Mathew, will be a valuable asset throughout the
fundraising process and in structuring our clinics. For
additional information on Mr. Mathew, please refer to our 8-K
announcement."
Glaucoma is the second leading cause of blindness, affecting
over 70 million people worldwide. PNT has been proven
(through studies completed over the last 10 yrs) to be a safe,
effective, non-invasive and a cost effective alternative for
treatment for glaucoma and ocular hypertension. The 2-minute
treatment has been developed, patented, and distributed by Sunridge
International, wholly owned subsidiary, Ophthalmic International
www.oi-pnt.com.
|
CONTACT:
|
|
|
Jeff Smith, Sunridge
International
|
|
|
T:
+1-480-837-6165
|
|
|
e-mail:
info@sunridgeint.com
|
|
|
|
|
|
MEDIA:
|
|
|
Victor Webb, Marston Webb
International
|
|
|
T: (212) 684-6601
|
|
|
e-mail:
marwebint@cs.com
|
|
|
|
SOURCE Sunridge International